Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

Aphria to Acquire German CC Pharma for Approximately $62.2 Million

Aphria to Acquire German CC Pharma for Approximately $62.2 MillionAphria Inc. (NYSE: APHA) announced on November 8th that the company has proposed an acquisition of CC Pharma GmbH (CC Pharma) for up to approximately $62.2 million. The company’s acquisition of CC Pharma, a German distributor of pharmaceutical products to over 13,000 German pharmacies, will strengthen Aphria’s foothold in Germany when the transaction is expected to close sometime in January of 2019. The company has agreed to pay €24.5 million in cash to CC Pharma when the transaction agreement closes in 2019 with another €23.5 million after the close if CC Pharma performs to meet certain achievement milestones.

Chief Executive Officer of Aphria, Vic Neufeld, said, “This acquisition strengthens our foothold in Germany, one of the most highly sought-after medical cannabis markets in the world.” The CEO of Aphria added that the company’s acquisition of CC Pharma will provide Aphria with access to German pharmacies while moving the company further along in its current global expansion plan.

CC Pharma’s portfolio of products that it distributes to its pharmacy connections within Germany has led the company that was founded in 1999 to an annual revenue stream that is estimated to be at over $259 million.

Learn more about Aphria Inc. and other hot cannabis companies. See our Cannin Report and subscribe to our Weekly Cannin Chronicle for more information and a FREE stock tip.


Aphria to Acquire German CC Pharma for Approximately $62.2 Million

Cannin Investment Group: Your Hemp Stocks Experts is your trusted resource for hemp stocks. Our team of financial experts evaluates all emerging hemp stock investing opportunities. We aggregate hundreds of hours of market research to provide tips on the best hemp stocks for 2020. 

Use Cannin as your resource for:

Is it too late to invest in hemp stocks? No! This is the perfect time to invest.

Wall Street analysts expect the global cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in hemp stocks is now. 

Are you interested in hemp stocks like GW Pharmaceuticals, Charlotte’s Web, Canopy Growth, or Hemp Inc.?

Are you looking to buy stock in hemp companies or marijuana companies in 2020? Interested in emerging penny hemp stocks? Interested in leveraging the power of algorithmic stock trades to profit from hemp stocks? Looking for the best Canadian cannabis stocks to invest in? We can help.

Predict price movements of hemp stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +25% Gains in 2020
  • +49.8% Gains in 2019
  • Backtested since 2012

At Cannin, we’re so confident you’ll love our algotrading hemp stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best hemp stocks – we’ll show you how at

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Penny Hemp Stocks